Urology
Volume 54, Issue 6 , Pages 988-993 , December 1999

Nephron-sparing surgery for renal cell carcinoma—is tumor size a suitable parameter for indication?

  • Joerg Miller

      Affiliations

    • Department of Urology, Justus-Liebig University, Giessen, Germany
    • Corresponding Author InformationReprint requests: Joerg Miller, M.D., Urology Department, Justus-Liebig University, Klinikstrasse 29, Giessen 35385, Germany
  • ,
  • Claus Fischer

      Affiliations

    • Department of Urology, Justus-Liebig University, Giessen, Germany
  • ,
  • Roland Freese

      Affiliations

    • Department of Urology, Justus-Liebig University, Giessen, Germany
  • ,
  • Michael Altmannsberger

      Affiliations

    • Institute of Pathology, Justus-Liebig University, Giessen, Germany
  • ,
  • Wolfgang Weidner

      Affiliations

    • Department of Urology, Justus-Liebig University, Giessen, Germany

Received 28 September 1998 ,Revised 28 June 1999 ,Accepted 28 June 1999.

References 

  1. Herrlinger A, Schott G, Schafhauser W, et al.  Die Bedeutung des Tumordurchmessers beim Nierenzellkarzinom. Urologe A. 1992;31:70–75
  2. Selli C, Hinshaw WM, Woodard BH, et al.  Stratification of risk factors in renal cell carcinoma. Cancer. 1983;52:899–903
  3. Ljunberg B, Stenling R, Roos G. Prognostic value of deoxyribonucleic acid content in metastatic renal cell carcinoma. J Urol. 1986;136:801–804
  4. Marberger M. Organerhaltende Nierentumorexcision. Akt Urol. 1988;19:58–66
  5. Banner BF, Ernstoff MS, Bahnson RR, et al.  Quantitative DNA analysis of small renal cortical neoplasms. Hum Pathol. 1991;22:247–253
  6. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–663
  7. Zincke H, Ghavamian R. Partial nephrectomy for renal cell cancer is here to stay—more data on this issue. J Urol. 1998;159:1161–1162(editorial)
  8. DeKernion JB, Mukamel E, Ritchie AWS, et al.  Prognostic significance of the DNA content of renal cell carcinoma. Cancer. 1989;64:1669–1673
  9. Klöppel G, Knofel WT, Baisch H, et al.  Prognosis of renal cell carcinoma related to nuclear grade, DNA content and Robson stage. Eur Urol. 1986;12:426–431
  10. Thoenes W, Stoerkel ST, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). Pathol Res Pract. 1986;181:125–143
  11. Böcking A. DNA—Zytometrie und Automation in der klinischen Diagnostik. Verh Dtsch Ges Pathol. 1990;74:176–185
  12. Ljunberg B, Nordenson J, Roos G. Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma. Eur Urol. 1991;19:59–64
  13. Rainwater LM, Farrow GM, Zincke H, et al.  Renal cell carcinomas in young and old patients—comparison of prognostic pathological variables (cell type, tumor grade and stage, and DNA ploidy pattern) and their impact on disease outcome. Urology. 1991;38:1–5
  14. Chin JL, Pontes JE, Frankfurt OS. Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J Urol. 1985;133:582–585
  15. Marroncle M, Irani J, Dore B, et al.  Prognostic value of histological grade and nuclear grade in renal adenocarcinoma. J Urol. 1994;151:1174–1176
  16. Ekfors TO, Lipasti J, Nurmi MJ, et al.  Flow cytometric analysis of the DNA profile of renal cell carcinoma. Pathol Res Pract. 1987;182:58–62
  17. Ellis WE, Bauer KD, Oyasu R, et al.  Flow cytometric analysis of small renal tumors. J Urol. 1992;148:1774–1777
  18. Fischer CG, Miller J, Freese R, et al.  Durchflußzytometrische DNA—Analyse als zusätzlicher Entscheidungsparameter in der organerhaltenden Nierentumorchirurgie. Akt Urol. 1996;27:146–151
  19. Vindelöf LL. Flow cytometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch B Cell Pathol. 1977;24:227–242
  20. Hiddemann W, Schumann J, Andreeff M, et al.  Convention on nomenclature for DNA cytometry. Cytometry. 1984;5:445–446
  21. Rainwater LM, Hosaka Y, Farrow GM, et al.  Well differentiated clear cell renal carcinoma (significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry). J Urol. 1987;137:15–20
  22. Masters JRW, Camplejohn RS, Parkinson MC, et al.  Does DNA flow cytometry give useful prognostic information in renal parenchymal adenocarcinoma?. Br J Urol. 1992;70:364–369
  23. Kletscher BA, Quian J, Bostwick DG, et al.  Prospective analysis of multifocality in renal cell carcinoma (influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy). J Urol. 1995;153:904–906
  24. Whang M, O’Toole K, Bixon R, et al.  The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy. J Urol. 1995;154:968–970
  25. Ljunberg B, Forslund G, Stenling R, et al.  Prognostic significance of the DNA content in renal cell carcinoma. J Urol. 1986;135:422–426
  26. Ljunberg B, Larsson P, Roos G, et al.  Cell kinetics of renal cell carcinoma studied with in vivo jododeoxyuridine incorporation and flow cytometry. J Urol. 1994;151:1509–1513
  27. Ljunberg B, Larsson P, Stenling R, et al.  Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma. J Urol. 1991;146:697–699
  28. Ljunberg B, Stenling R, Roos G. DNA content and prognosis in renal cell carcinoma—a comparison between primary tumors and metastasis. Cancer. 1986;57:2346–2350
  29. diSilverio F, Gallucci M, Flammia GP, et al.  Biological and clinical implications of cellular DNA content in renal cell carcinomas. Eur Urol. 1992;21(suppl 1):43–47
  30. Wolman SR, Camuto PM, Golimba M, et al.  Cytogenetic, flow cytometric, and ultrastructural studies of twenty-nine nonfamilial human renal carcinomas. Cancer Res. 1988;48:2890–2892
  31. Stöckle M, Störkel S, Mielke R, et al.  Characterization of conservatively resected renal tumors using automated image analysis DNA cytometry. Cancer. 1991;68:1926–1931
  32. Leyh H, Lehmer A, Hartung R. Patterns of ploidy in renal cell carcinoma. Prog Clin Biol Res. 1992;378:187–193

PII: S0090-4295(99)00347-7

Urology
Volume 54, Issue 6 , Pages 988-993 , December 1999